BIFIDO Co., Ltd. (KOSDAQ:238200)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,490.00
-5.00 (-0.14%)
At close: Aug 1, 2025, 3:30 PM KST
-0.14%
Market Cap29.28B
Revenue (ttm)14.13B
Net Income (ttm)-4.13B
Shares Out8.18M
EPS (ttm)-504.41
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,277
Average Volume9,537
Open3,510.00
Previous Close3,495.00
Day's Range3,440.00 - 3,550.00
52-Week Range2,750.00 - 4,820.00
Beta1.22
RSI55.94
Earnings DateAug 14, 2025

About Endeavor Group Holdings

BIFIDO Co., Ltd. produces probiotics-based products in South Korea and internationally. It offers bifidobacterium strain products, such as BGN4 for immune modulating; BORI used to treat rotavirus infection in infants; and AD011 for general intestinal health problems. The company was founded in 1999 and is headquartered in Hongcheon-eup, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1999
Employees 83
Stock Exchange KOSDAQ
Ticker Symbol 238200
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.